Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06916247

Evaluation of AI Cost Prediction Model to Enroll Patients in Complex Care Management Program

Evaluation of MA Proactive Care Program Using Cost Prediction Model With Randomized Waitlist

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
5,000 (estimated)
Sponsor
University of California, Los Angeles · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Currently, UCLA Health (specifically the Office of Population Health and Accountable Care, or OPHAC) runs a complex care management program called Proactive Care (goal is to reduce care utilization by providing personalized care navigation/case management). Every month, an AI Population Risk tool runs to identify around 250 of the 480,000 or so UCLA primary care patients, and RNs contact these 250 patients to enroll in Proactive Care. Starting in December 2024, OPHAC launched a new method of enrolling UCLA's Medicare Advantage (MA) patients into Proactive Care: an AI Cost Prediction model. The idea is the same-- the top 250 highest predicted cost patients will be enrolled in Proactive Care. The investigators will evaluate this model and subsequent enrollment into the program by randomizing the waitlist of MA patients waiting to enroll in Proactive Care, thereby creating a control group. The top 500 highest predicted cost patients will be identified each month, and following a 1:1 randomization, 250 will be contacted for enrollment and the rest will be put on a wait-list control group for 10 months unless otherwise requested by their provider to be enrolled in the Proactive Care program earlier.

Conditions

Interventions

TypeNameDescription
BEHAVIORALComplex care management programIntensive outpatient care management program that includes contact from nurses and case managers to help coordinate care, detect clinical red flags, and reduce overall unplanned acute care utilization.

Timeline

Start date
2024-08-16
Primary completion
2025-09-09
Completion
2026-05-12
First posted
2025-04-08
Last updated
2026-01-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06916247. Inclusion in this directory is not an endorsement.